The role of peri-operative treatment in resectable liver metastases of colorectal cancer
Synchronous or metachronous colorectal liver metastases (CLMs), although being the expression of systemic disease, allow a curative approach for about 25—35% of patients. Patients presenting with CLMs should receive a multimodal management in order to increase the number of patients undergoing R0 su...
Main Authors: | Alexander Stein, Joern Rüssel, Stefan Peinert, Dirk Arnold |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2010-11-01
|
Series: | Therapeutic Advances in Medical Oncology |
Online Access: | https://doi.org/10.1177/1758834010375095 |
Similar Items
-
Peri-operative chemotherapy for the treatment of resectable liver metastases from colorectal cancer: A systematic review and meta-analysis of randomized trials
by: Schmiegel Wolff, et al.
Published: (2010-06-01) -
Peri-operative chemotherapy in the management of resectable colorectal cancer pulmonary metastases
by: Hawkes Eliza A, et al.
Published: (2012-08-01) -
Laparoscopic liver resection for colorectal metastases – treatment results
by: Arpad Ivanecz, et al.
Published: (2017-04-01) -
Angiogenesis in resected colorectal liver metastases
by: Sutton, Christopher Derek
Published: (2003) -
Systemic treatment of liver metastases from colorectal cancer
by: Alexander Stein, et al.
Published: (2013-05-01)